{"DataElement":{"publicId":"3362012","version":"1","preferredName":"Disease or Disorder FIGO Staging System and Modified World Health Organization [WHO] Prognostic Scoring System for Gestational Trophoblastic Neoplasms Tumor size Diagnosis Score","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:A system for defining prognosis for gestational trophoblastic neoplasia. In this system, the FIGO stage is represented by an Roman numeral, followed by the modified WHO score depicted as an Arabic numeral and separated by a colon (e.g., Stage II:4, Stage IV:9). Scores of 0-6 are considered low-risk and scores greater than 6 are considered high-risk._The size of a tumor in its greatest dimension._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation._A system for defining prognosis for gestational trophoblastic neoplasia. In this system, the FIGO stage is represented by an Roman numeral, followed by the modified WHO score depicted as an Arabic numeral and separated by a colon (e.g., Stage II:4, Stage IV:9). Scores of 0-6 are considered low-risk and scores greater than 6 are considered high-risk._The size of a tumor in its greatest dimension._A number or range of numeric values measuring performance, function, quality, or ability.","longName":"Dise_FIGO_Tumo_Diag_FIGO_Tumo_","context":"NRG","contextVersion":"1","DataElementConcept":{"publicId":"3362005","version":"1","preferredName":"Disease or Disorder FIGO Staging System and Modified World Health Organization [WHO] Prognostic Scoring System for Gestational Trophoblastic Neoplasms Tumor Size Diagnosis","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:A system for defining prognosis for gestational trophoblastic neoplasia. In this system, the FIGO stage is represented by an Roman numeral, followed by the modified WHO score depicted as an Arabic numeral and separated by a colon (e.g., Stage II:4, Stage IV:9). Scores of 0-6 are considered low-risk and scores greater than 6 are considered high-risk._The size of a tumor in its greatest dimension._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","longName":"2404658v1.00:14101405v1.00","context":"NRG","contextVersion":"1","ObjectClass":{"publicId":"2404658","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"005AD6E5-0651-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"PWEST","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"14101405","version":"1","preferredName":"FIGO Staging System and Modified World Health Organization [WHO] Prognostic Scoring System for Gestational Trophoblastic Neoplasms Tumor Size Diagnosis","preferredDefinition":"A system for defining prognosis for gestational trophoblastic neoplasia. In this system, the FIGO stage is represented by an Roman numeral, followed by the modified WHO score depicted as an Arabic numeral and separated by a colon (e.g., Stage II:4, Stage IV:9). Scores of 0-6 are considered low-risk and scores greater than 6 are considered high-risk._The size of a tumor in its greatest dimension._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","longName":"C99408:C120284:C15220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Staging System and Modified World Health Organization [WHO] Prognostic Scoring System for Gestational Trophoblastic Neoplasms","conceptCode":"C99408","definition":"A system for defining prognosis for gestational trophoblastic neoplasia. In this system, the FIGO stage is represented by an Roman numeral, followed by the modified WHO score depicted as an Arabic numeral and separated by a colon (e.g., Stage II:4, Stage IV:9). Scores of 0-6 are considered low-risk and scores greater than 6 are considered high-risk.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Tumor Size","conceptCode":"C120284","definition":"The size of a tumor in its greatest dimension.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"00C93A72-EC0D-626D-E063-731AD00A541D","latestVersionIndicator":"Yes","beginDate":"2023-07-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-07-18","modifiedBy":"KUMMEROA","dateModified":"2023-07-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B749E724-D433-0EC8-E040-BB89AD43503D","latestVersionIndicator":"Yes","beginDate":"2012-01-24","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-24","modifiedBy":"KUMMEROA","dateModified":"2023-07-18","changeDescription":" Changed from CTEP to GOG for REBOYJ by script Thu Aug 1 14:45:44 EDT 2013","administrativeNotes":"2023.7.18 Updated def for 'No Vale Exists'. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3362008","version":"1","preferredName":"FIGO Staging System and Modified World Health Organization [WHO] Prognostic Scoring System for Gestational Trophoblastic Neoplasms Tumor size Score Tumor Size","preferredDefinition":"A system for defining prognosis for gestational trophoblastic neoplasia. In this system, the FIGO stage is represented by an Roman numeral, followed by the modified WHO score depicted as an Arabic numeral and separated by a colon (e.g., Stage II:4, Stage IV:9). Scores of 0-6 are considered low-risk and scores greater than 6 are considered high-risk._The size of a tumor in its greatest dimension._A number or range of numeric values measuring performance, function, quality, or ability.","longName":"FIGO_Tumo_Scor","context":"NRG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"GREATER THAN OR EQUAL TO 5 CM","valueDescription":"SCORE 2-TUMOR SIZE GREATER THAN OR EQUAL TO 5 CM","ValueMeaning":{"publicId":"3362009","version":"1","preferredName":"SCORE 2-TUMOR SIZE GREATER THAN OR EQUAL TO 5 CM","longName":"3362009","preferredDefinition":"SCORE 3-TUMOR SIZE GREATER THAN OR EQUAL TO 5 CM","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B749E724-D48A-0EC8-E040-BB89AD43503D","latestVersionIndicator":"Yes","beginDate":"2012-01-24","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B749E724-D4A3-0EC8-E040-BB89AD43503D","beginDate":"2012-01-24","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-24","modifiedBy":"ONEDATA","dateModified":"2012-01-24","deletedIndicator":"No"},{"value":"3 TO 4.9 CM","valueDescription":"SCORE 1-TUMOR SIZE 3 TO 4.9 CM","ValueMeaning":{"publicId":"3362010","version":"1","preferredName":"SCORE 1-TUMOR SIZE 3 TO 4.9 CM","longName":"3362010","preferredDefinition":"SCORE 1-TUMOR SIZE 3 TO 4.9 CM","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B749E724-D4AD-0EC8-E040-BB89AD43503D","latestVersionIndicator":"Yes","beginDate":"2012-01-24","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B749E724-D4C6-0EC8-E040-BB89AD43503D","beginDate":"2012-01-24","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-24","modifiedBy":"ONEDATA","dateModified":"2012-01-24","deletedIndicator":"No"},{"value":"LESS THAN 3 CM","valueDescription":"SCORE 0-TUMOR SIZE LESS THAN 3 CM","ValueMeaning":{"publicId":"3362011","version":"1","preferredName":"SCORE 0-TUMOR SIZE LESS THAN 3 CM","longName":"3362011","preferredDefinition":"SCORE 0-TUMOR SIZE LESS THAN 3 CM","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B749E724-D4D0-0EC8-E040-BB89AD43503D","latestVersionIndicator":"Yes","beginDate":"2012-01-24","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B749E724-D4E9-0EC8-E040-BB89AD43503D","beginDate":"2012-01-24","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-24","modifiedBy":"ONEDATA","dateModified":"2012-01-24","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"14111451","version":"1","preferredName":"FIGO Staging System and Modified World Health Organization [WHO] Prognostic Scoring System for Gestational Trophoblastic Neoplasms Tumor Size Score","preferredDefinition":"A system for defining prognosis for gestational trophoblastic neoplasia. In this system, the FIGO stage is represented by an Roman numeral, followed by the modified WHO score depicted as an Arabic numeral and separated by a colon (e.g., Stage II:4, Stage IV:9). Scores of 0-6 are considered low-risk and scores greater than 6 are considered high-risk._The size of a tumor in its greatest dimension._A number or range of numeric values measuring performance, function, quality, or ability.","longName":"14111451v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Staging System and Modified World Health Organization [WHO] Prognostic Scoring System for Gestational Trophoblastic Neoplasms","conceptCode":"C99408","definition":"A system for defining prognosis for gestational trophoblastic neoplasia. In this system, the FIGO stage is represented by an Roman numeral, followed by the modified WHO score depicted as an Arabic numeral and separated by a colon (e.g., Stage II:4, Stage IV:9). Scores of 0-6 are considered low-risk and scores greater than 6 are considered high-risk.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Tumor Size","conceptCode":"C120284","definition":"The size of a tumor in its greatest dimension.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"00ED010E-6EA8-11E4-E063-731AD00A8D77","latestVersionIndicator":"Yes","beginDate":"2023-07-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-07-20","modifiedBy":"KUMMEROA","dateModified":"2023-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B749E724-D478-0EC8-E040-BB89AD43503D","latestVersionIndicator":"Yes","beginDate":"2012-01-24","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-24","modifiedBy":"KUMMEROA","dateModified":"2023-07-20","changeDescription":" Changed from CTEP to GOG for REBOYJ by script Thu Aug 1 14:45:44 EDT 2013","administrativeNotes":"2023.7.20 Updated def for 'No Value Exists'. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4104991","version":"1","longName":"GOG-0275","context":"NRG"}]}],"AlternateNames":[{"name":"Dise_FIGO_Tumo_Diag_FIGO_Tumo_","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"Largest tumor size, including","type":"Preferred Question Text","description":"Largest tumor size, including uterine tumor WHO score","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B749E724-D4F3-0EC8-E040-BB89AD43503D","latestVersionIndicator":"Yes","beginDate":"2012-01-24","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-24","modifiedBy":"KUMMEROA","dateModified":"2023-07-20","changeDescription":" Changed from CTEP to GOG for REBOYJ by script Thu Aug 1 14:45:44 EDT 2013","administrativeNotes":"2023.7.20 Updated def for 'No Value Exists'. ak","unresolvedIssues":null,"deletedIndicator":"No"}}